Αποτελέσματα Αναζήτησης
23 Ιουν 2005 · Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.
Background: Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.
1 Ιαν 2023 · Inhaled nitric oxide (iNO) is widely available for the treatment of multiple conditions such as hypoxemia due to pulmonary hypertension of the newborn (i.e., > 34 weeks of gestational age), acute respiratory distress syndrome, myocardial infarction, and it is under investigation as an antimicrobial agent.
15 Σεπ 2015 · Inhaled nitric oxide (iNO) therapy as a selective pulmonary vasodilator in cardiac surgery has been one of the most significant pharmacological advances in managing pulmonary hemodynamics and life threatening right ventricular dysfunction and failure.
Abstract. Background: Inhaled nitric oxide (iNO) is a rescue treatment for severe hypoxemia in the intensive care unit setting. Objective: To evaluate the effectiveness and safety of iNO in adult patients with severe hypoxemia before and during transport to a tertiary care center.
29 Μαΐ 2009 · This 'Bench-to-bedside' review focuses on the mechanisms of action of iNO and its clinical applications, with emphasis on acute lung injury and the acute respiratory distress syndrome.
20 Μαΐ 2020 · Nitric oxide donor molecules, such as organic nitrates and sodium nitroprusside, are used as systemic agents to treat pulmonary hypertension (PHT), heart failure, angina, and erectile dysfunction [1]. Inhaled nitric oxide (iNO) gas was approved in 1999 by the FDA to treat hypoxic newborns [2].
